Predictive Factors and Consequences of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Hypertrophic Cardiomyopathy
Related studies linked through entity extraction aliases.
Hypertrophic Cardiomyopathy Pilot Study
- Status
- COMPLETED
- Phase
- N/A
Molecular and Imaging Studies of Cardiovascular Health and Disease
- Status
- RECRUITING
- Phase
- N/A
Non-Invasive Evaluation of Myocardial Stiffness by Elastography in Pediatric Cardiology (Elasto-Pédiatrie)
- Status
- COMPLETED
- Phase
- NA
Hypertrophic Cardiomyopathy Symptom Release by BX1514M
- Status
- COMPLETED
- Phase
- PHASE2
Perfusion Imaging With Myocardial Contrast Echocardiography in HCM
- Status
- UNKNOWN
- Phase
- NA
Hyper-synchronicity in Hypertrophic Cardiomyopathy (HCM) : Description, Mechanism and Origin With a Multi-imaging Approach to Predict Dual Chamber Pacing Response
- Status
- COMPLETED
- Phase
- NA
Exercise in Genetic Cardiovascular Conditions
- Status
- COMPLETED
- Phase
- N/A
New Diagnostic Strategy in Hypertrophic Cardiomyopathy
- Status
- UNKNOWN
- Phase
- N/A
Study of Hypertrophic Cardiomyopathy Under Stress Conditions. Concordance Between Two Complementary Tests: Stress MRI and Exercice Stress Echocardiography
- Status
- UNKNOWN
- Phase
- NA
Pediatric Cardiomyopathy Mutation Analysis
- Status
- RECRUITING
- Phase
- N/A
Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure
- Status
- WITHDRAWN
- Phase
- PHASE3
Morbidity and Mortality in Patients With Hypertrophic Cardiomyopathy: a CALIBER Study
- Status
- UNKNOWN
- Phase
- N/A
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Assessment of Wall Thickness in Hypertrophic Cardiomyopathy
- Status
- COMPLETED
- Phase
- N/A
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
- Status
- COMPLETED
- Phase
- PHASE2
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
- Status
- UNKNOWN
- Phase
- N/A
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
- Status
- COMPLETED
- Phase
- N/A